Search Results 1241-1250 of 17617 for corticosteroid

1. Gastroenterology and Hepatology - Clinical trials

   Patients enrolled will be those who failed all attempts at standard treatment including antibiotics, corticosteroids, immunomodulator, and/or biologic therapy.

2. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   ... corticosteroids (unless used to treat drug-related adverse events).Topical, ocular, intra-articular, intranasal, inhalational corticosteroids (with minimal ...

3. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   The use of inhaled corticosteroids ... Screening CNS radiographic study ≥ 4 weeks from completion of radiotherapy and ≥ 2 weeks from discontinuation of ...

4. A Study of Clinical Outcomes Data and Imaging for Patients Receiving Cartiform for Articular Cartilage Defects as Treatment

   Pain medication other than NSAIDs or acetaminophen, chronic use of anticoagulants, corticosteroids, growth hormone, or testosterone. Diagnosis in the ...

5. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) (MV-s-NAP) in Patients with Metastatic Breast Cancer - Mayo Clinic

   * Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids * Exposure to household contacts =\< 15 months old or ...

6. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

   The use of physiologic doses of corticosteroids may be approved after consultation with the Sponsor. Has known history of active tuberculosis; Has known ...

7. A Study of ART24 in Subjects Recently Cured of a Clostridioides difficile Infection (CDI) - Mayo Clinic

   Receiving, or plans to receive, treatment with systemic corticosteroids equivalent to > 10 mg prednisone per day;; Receiving, or plans to receive ...

8. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

   Any patient receiving chronic corticosteroid administration prior to study enrollment is ineligible; Baseline prolongation of the rate-corrected QT interval ...

9. Returning Patient - Appointments at Mayo Clinic

   Have you seen a Mayo Clinic provider for this health concern in the last 3 years? · Yes · No.

10. AUTO1 in Relapsed or Refractory B-ALL - Mayo Clinic

    Participation eligibility · Steroids: Therapeutic doses of corticosteroids (greater than 10 mg daily of prednisone or its equivalent) within 7 days of ...